CRVO – cervomed inc. (US:NASDAQ)
Stock Stats
News
CervoMed Inc. (NASDAQ: CRVO) had its price target raised by analysts at Canaccord Genuity Group Inc. from $50.00 to $65.00. They now have a "buy" rating on the stock.
CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
CervoMed to Participate in Upcoming Investor Conferences
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
CervoMed Announces Presentation of Biomarker Data from the AscenD-LB Phase 2a Trial and Preclinical Data Supporting Potential of Neflamapimod in Tau-Mediated Disease at AD/PD ™ 2024
Form S-1 CervoMed Inc.
Form DEF 14A CervoMed Inc. For: Jun 14
Form 8-K CervoMed Inc. For: Apr 22
Form SC 13G CervoMed Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Form 8-K CervoMed Inc. For: Apr 01
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.